First 7 Tesla MRI scanner in Flanders opens up new possibilities for medical research
The five Flemish universities and four university hospitals are pooling their expertise in a unique research facility. The ultra-powerful scanner is designed to help scientists study brain disorders, tumours and other diseases down to the smallest detail.
Zellik, 16 November 2026 – What does Alzheimer’s disease look like at the level of small brain structures? What changes occur in tissues as a condition develops? And how can we better understand these processes to refine future diagnoses and treatments? With the inauguration of the first 7 Tesla MRI scanner in Flanders, researchers are gaining new opportunities to investigate such questions. The state-of-the-art scanner, located at the Research Park in Zellik, brings together the five Flemish universities and four university hospitals within a single shared research infrastructure: Flanders 7T.
The Vrije Universiteit Brussel (VUB) took the initiative to bring the scanner to Flanders and is coordinating the project. The infrastructure is designed to give researchers from various disciplines and institutions access to imaging technology that provides an exceptionally detailed view of the anatomy, functioning and metabolic processes of the human body.

An exceptional magnetic field strength
The new scanner operates with a magnetic field of 7 Tesla. That is more than twice as strong as the 3-Tesla scanners used in many hospitals. This higher field strength produces a stronger MRI signal, enabling researchers to visualise certain structures and tissues with greater clarity and to study subtle differences in tissue more effectively. Moreover, the possibilities extend beyond anatomical imaging. Thanks to the stronger signal, scientists can also investigate certain metabolic processes and molecules that are more difficult to visualise using a conventional MRI. For example, they can study changes in the concentration of sodium, phosphorus or glucose. This provides new insights into what is happening in the body at a cellular and molecular level.
The 7 Tesla MRI scanner is the first of its kind in Flanders and will be used, amongst other things, for research into epilepsy, multiple sclerosis, dementia, tumours, kidney disorders and cartilage degeneration. The development of new MRI techniques and applications in neurology, oncology and orthopaedics is also on the agenda.

A unique collaboration
Flanders 7T brings together the five Flemish universities – Vrije Universiteit Brussel, KU Leuven, the University of Antwerp, Ghent University and Hasselt University – and the four university hospitals: UZ Brussel, UZ Leuven, UZA and UZ Gent. By jointly developing and utilising the infrastructure, researchers can pool their expertise in medical imaging, radiology, neurology, biomedical technology, physics and artificial intelligence. This collaboration makes it possible to set up research projects that transcend the boundaries of a single institution or discipline.
VUB Rector Jan Danckaert: “With Flanders 7T, the Flemish universities and university hospitals are demonstrating what is possible when we pool our knowledge, infrastructure and expertise. This scanner is much more than a high-tech device: it creates a shared platform on which researchers from different disciplines can work together to answer new scientific questions. In this way, we are not only strengthening medical research in Flanders, but also building the healthcare system of tomorrow.”
From sharper images to a better understanding of disease
The 7 Tesla MRI scanner is, first and foremost, a research tool. Over the coming years, scientists will systematically investigate the possibilities and limitations of ultra-high-field MRI and develop and validate new imaging techniques. This will be done, amongst other things, through research involving human subjects. There is significant potential in gaining a better understanding of disease processes. By visualising minor anatomical abnormalities, functional changes and metabolic processes with greater precision, researchers hope to gain new insights into the aetiology and progression of conditions. In the long term, this knowledge could contribute to earlier or more accurate diagnosis, better monitoring of disease processes and more targeted treatments.
Johan de Mey, professor at the VUB, head of the Radiology Department at UZ Brussel and project leader of Flanders 7T: “The added value of 7 Tesla lies not only in the fact that we can visualise smaller structures more clearly. We can also gather information about processes in the body that are much more difficult to access using conventional MRI. Think of changes in metabolism or the functioning of certain areas of the brain. By combining this information, we can investigate disease processes from different angles. That is precisely what makes this infrastructure so interesting.”
Hubert Raeymaekers, visiting professor at VUB, Manager ofFlanders 7T: “We have succeeded in bringing together Flanders’ leading MRI expertise within a single project centred on 7T MRI. It is therefore our aim to help facilitate the transition from scientific research to clinical practice – in collaboration with GE HealthCare.”
Kelly Londy, President and CEO of MR and Women’s Health at GE HealthCare: “This milestone demonstrates what is possible when researchers, clinicians and technological innovators join forces around a shared ambition. Our 7T MRI technology provides the Flanders 7T consortium with a powerful platform to explore key research questions in the fields of neuroscience, musculoskeletal imaging and advanced MR methods. At the same time, we are building the knowledge and scientific foundation that can help shape the future of MRI. We are proud to have contributed to the realisation of this ambition and look forward to continuing our collaboration as this promising new chapter begins.”
An investment in the medical imaging of tomorrow
With this investment, the participating institutions are strengthening Flanders’ position in international research into ultra-high-field MRI. The realisation of Flanders 7T was made possible thanks to financial support from the Flemish Government, via the Department of Labour, Economy, Science, Innovation and Social Economy (WEWIS), and the Research Foundation of the Flemish Government (FWO). The Flemish Government invested 2.1 million euros in the project. The FWO also allocated 2 million euros for the research infrastructure.
Ben Weyts, Deputy Minister-President of the Flemish Government and Flemish Minister for the Flemish Periphery: “Flanders may seem small, but our ambition is great: we are pioneers in many fields and invest heavily in innovation. I am also pleased that this investment has been channelled into the Flemish Periphery: the heart of the country, where people are also working hard. We should certainly be a little prouder of everything that is happening here.”
Cieltje Van Achter, Flemish Minister for Brussels: “What remains hidden within the human body today may soon be made visible by researchers using this scanner. This opens up new perspectives for research into diseases such as Alzheimer’s, epilepsy and cancer. This impressive project demonstrates just how much scientific clout we have here in Flanders and Brussels. With this Flemish investment, we are bringing together researchers from across Flanders, pooling our scientific expertise and giving a strong boost to medical research that, in the long term, could make a world of difference to patients.”
Further information:
Contact:
Hubert Raeymaekers
Manager Flanders 7T
Hubert.Raeymaekers@uzbrussel.be
Tineke Sonck



